Latest reported dividend
Not available
MMM · NYSE
Surgical & Medical Instruments & Apparatus
Not available
Not available
Not reported
48.1%
111.9%
These ratios relate cash dividends paid by the company to its earnings and free cash flow for the stated period. They are not dividend yields or measures of a guaranteed future payout.
No matching dividend events have been collected. This does not establish that the company pays no dividend.
| Reporting period | Measure | USD millions | Filing |
|---|---|---|---|
| Dec 31, 2025From Jan 1, 2025 | Operating cash flow | 2,306.0 | SEC filingFeb 3, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Net income | 3,250.0 | SEC filingFeb 3, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Common-stock cash dividends | 1,562.0 | SEC filingFeb 3, 2026 |
| Dec 31, 2025From Jan 1, 2025 | Capital expenditures (PP&E) | 910.0 | SEC filingFeb 3, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Operating cash flow | 1,819.0 | SEC filingFeb 3, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Net income | 4,173.0 | SEC filingFeb 3, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Common-stock cash dividends | 1,982.0 | SEC filingFeb 3, 2026 |
| Dec 31, 2024From Jan 1, 2024 | Capital expenditures (PP&E) | 1,181.0 | SEC filingFeb 3, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Operating cash flow | 6,680.0 | SEC filingFeb 3, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Net income | -6,995.0 | SEC filingFeb 3, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Common-stock cash dividends | 3,311.0 | SEC filingFeb 3, 2026 |
| Dec 31, 2023From Jan 1, 2023 | Capital expenditures (PP&E) | 1,615.0 | SEC filingFeb 3, 2026 |
| Dec 31, 2022From Jan 1, 2022 | Operating cash flow | 5,591.0 | SEC filingFeb 5, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Net income | 5,777.0 | SEC filingFeb 5, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Common-stock cash dividends | 3,369.0 | SEC filingFeb 5, 2025 |
| Dec 31, 2022From Jan 1, 2022 | Capital expenditures (PP&E) | 1,749.0 | SEC filingFeb 5, 2025 |
| Dec 31, 2021From Jan 1, 2021 | Operating cash flow | 7,454.0 | SEC filingFeb 7, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Net income | 5,921.0 | SEC filingFeb 7, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Common-stock cash dividends | 3,420.0 | SEC filingFeb 7, 2024 |
| Dec 31, 2021From Jan 1, 2021 | Capital expenditures (PP&E) | 1,603.0 | SEC filingFeb 7, 2024 |
A higher payout ratio can reflect a larger dividend, lower earnings, or both. Capital spending also affects the FCF denominator. The accounting context matters, especially for financial firms, REITs, and business development companies.
Understand cash payout ratios · Regular vs. special dividendsSource: collected SEC filings. USYieldHub is not affiliated with or endorsed by the SEC or this issuer. Coverage is incomplete; amounts may be unadjusted for splits.